<DOC>
	<DOCNO>NCT02021864</DOCNO>
	<brief_summary>- Pregnant woman 24-26 gestational week recruited.Serum calcium 25 ( OH ) D evaluate woman mild hypocalcemia ( serum calcium 8-8.6 mg/dl ) 25 ( OH ) D le 30ng/ml enter study . . - Excluding criterion : gestational diabetes diabetes pregnancy , severe preeclampsia , chronic hypertension , fetal anomaly , oligohydramnios polyhydramnios , parathyroid disorder , hepatic renal disease , malnutrition , use anti- convulsive immunosuppressive drug . - Participants randomly assign two group intervention control group .Randomization do random number generator . Intervention group receive weekly vitamin D3 , 50,000 unit 8 week plus daily prenatal multivitamin contain elemental calcium 250 mg/day vitamin D3 400 unit , control group receive daily prenatal multivitamin . - At time delivery , serum calcium , 25 ( OH ) D mother , maternal weight gain study , Serum calcium 25 ( OH ) D newborns neonatal growth index ( length , weight , head circumference ) compare two group .</brief_summary>
	<brief_title>Vitamin D Treatment Hypocalcemic Pregnant Women</brief_title>
	<detailed_description />
	<mesh_term>Pregnancy Complications</mesh_term>
	<mesh_term>Hypocalcemia</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>gestational age 2426weeks , mild hypocalcemia ( ca=88.6mg/dl ) , singleton pregnancy , body mass index ( BMI ) 1926 moderate sever hypocalcemia ( ca &lt; 8mg/dl ) , gestational diabetes diabetes pregnancy , severe preeclampsia , chronic hypertension , fetal anomaly , oligohydramnios polyhydramnios , parathyroid disorder , hepatic renal disease , malnutrition , use anti convulsive immunosuppressive drug</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>hypocalcemia , pregnancy , vitamin D</keyword>
</DOC>